Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02449239
Title Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Viventia Bio
Indications

bladder urothelial carcinoma

Therapies

Oportuzumab monatox

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.